Skip to main content

Table 1 Adult survival statistics for all trials.

From: Methoxylation enhances stilbene bioactivity in Caenorhabditis elegans

Trial Concentration (μM) Mean lifespan (days) Relative survival (%) p(Logrank) n (failed, censor)
   Treated Control    
Resveratrol-trimethylether
1 100 9.7 12.16 80% 0.004 61,0
4 20 7.72 11.26 69% < 0.001 61,0
4 40 7.72 11.26 69% < 0.001 74,0
4 100 7.18 11.26 64% < 0.001 70,2
5 5 18.83 18.49 102% 0.91 46,3
5 20 16.41 18.49 89% 0.055 42,3
5 100 15.18 18.49 82% 0.005 37,6
6 20 9.02 15.32 59% < 0.0001 49,5
6 40 7.98 15.32 52% < 0.0001 51,0
6 100 7.54 15.32 49% < 0.0001 52,0
3-OH-5,4'- dimethoxystilbene
1 100 6.34 12.16 52% < 0.0001 53,0
2 20 11.05 11.05 100% 0.986 47,2
2 40 10.52 11.05 95% 0.234 40,1
6 20 10.38 15.32 68% < 0.0001 56,0
6 40 7.68 15.32 50% < 0.0001 54,1
6 100 6.56 15.32 43% < 0.0001 55,3
Pterostilbene
1 100 9.55 12.16 79% 0.005 69,9
4 20 10.43 11.26 93% 0.336 54,0
4 40 10 11.26 89% 0.035 65,1
4 100 8.07 11.26 72% < 0.0001 51,1
6 20 13.72 15.32 90% 0.058 55,1
6 40 14.41 15.32 94% 0.142 51,4
6 100 10.98 15.32 72% < 0.001 51,0
Desoxyrhapontigenin
1 100 10.64 12.16 88% 0.12 61,1
3 100 11.31 15.37 74% < 0.0001 36,0
3 200 11.61 15.37 76% < 0.0001 44,1
4 20 10.2 11.26 91% 0.12 74,0
4 40 10.38 11.26 92% 0.11 71,2
4 100 9.44 11.26 84% 0.003 50,0
6 20 14.18 15.32 93% 0.494 54,3
6 40 15.31 15.32 100% 0.48 59,1
6 100 13.63 15.32 89% 0.027 46,9
Pinostilbene
1 100 13.6 12.16 112% 0.062 68,1
2 20 10.04 11.05 91% 0.266 55,0
2 40 11.53 11.05 104% 0.319 42,5
3 100 16.9 15.37 110% 0.448 41,0
3 200 15.23 15.37 99% 0.411 42,5
6 20 14.24 15.32 93% 0.319 56,3
6 40 17.33 15.32 113% 0.085 60,0
6 100 16.24 15.32 106% 0.724 51,2
Resveratrol
1 100 12.18 12.16 100% 0.867 70,3
2 20 11.85 11.05 107% 0.182 48,4
2 40 10.53 11.05 95% 0.924 55,0
3 100 16.64 15.37 108% 0.435 30,4
3 200 17 15.37 111% 0.337 38,0
6 20 14.65 15.32 96% 0.804 54,5
6 40 16.17 15.32 106% 0.501 59,0
6 100 17.55 15.32 115% 0.055 58,0
Piceatannol
2 20 11.72 11.05 106% 0.362 44,0
2 40 11.58 11.05 105% 0.5 37,9
3 100 17.78 15.37 116% 0.094 55,1
3 200 17.5 15.37 114% 0.166 55,1
6 20 13.71 15.32 89% 0.231 50,1
6 40 15.63 15.32 102% 0.75 50,1
6 100 16.6 15.32 108% 0.146 50,1